Financing type:  brokered private placement

Gross proceeds:  $3,620,851.20

Offering:  6,034,752 flow-through shares with 3,017,376 warrants

Offering price:  60 cents per flow-through share

Warrant exercise terms:  75 cents per listed share for a three-year period

Commissions in securities:  Research Capital Corp. (lead), 339,055 warrants; Roth Capital Partners, 17,845 warrants

Commission terms:  Each non-transferable warrant is exercisable at 50 cents for a three-year period.

Disclosure:  Refer to the company's prospectus supplement dated May 16, 2025, to the short form base shelf prospectus dated Aug. 2, 2023, and the company's news releases dated May 14, 2025, May 15, 2025, and May 29, 2025.